V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240016245 | 240008289 | 1.55 | 50.4 | Curative (C) | 2015-02-11 | 2015-09-03 | LENALIDOMIDE | N | N | 240034148 | GEMCARBO |
| 240016246 | 240012446 | 1.6 | 71.8 | Palliative (P) | 2015-08-16 | 2015-08-17 | Hydroxycarbamide | N | N | 240034166 | METHOTREXATE |
| 240016247 | 240008327 | 1.7 | 69.6 | null | 2013-09-11 | 2013-10-08 | Cisplatin + Topotecan | N | null | 240034332 | R IVAC |
| 240016248 | 240008344 | 0 | 70 | Palliative (P) | 2014-09-21 | 2014-09-21 | Brentuximab Vedotin | N | N | 240034422 | BRENTUXIMAB |
| 240016249 | 240014399 | 1.63 | 64.2 | Curative (C) | null | 2019-07-01 | FLAG + Idarubicin | null | null | 240034478 | DA |
| 240016250 | 240008366 | 1.56 | 95.9 | Palliative (P) | 2018-12-05 | 2018-12-10 | Brentuximab | null | null | 240034537 | BRENTUXIMAB |
| 240016251 | 240008384 | 1.55 | 76.6 | Palliative (P) | 2014-01-10 | 2014-08-21 | GemCarbo Days 1+8 | 2 | null | 240034689 | LENALIDOMIDE |
| 240016252 | 240008401 | null | 66.9 | Palliative (P) | 2017-03-26 | 2017-04-14 | Brentuximab | N | N | 240034778 | BRENTUXIMAB |
| 240016253 | 240008450 | 1.92 | 83.5 | Palliative (P) | null | 2015-11-22 | Cisplatin + Etoposide po&iv 3 day | 2 | null | 240035134 | HYDROXYCARBAMIDE |
| 240016254 | 240008467 | 1.79 | 55.5 | Palliative (P) | 2013-12-26 | 2014-01-15 | Trastuzumab 21 day loading dose | N | N | 240035318 | FLAG + IDARUBICIN |
| 240016255 | 240008473 | null | 86 | null | 2018-03-08 | 2018-03-09 | DA 3 + 10 | 99 | N | 240035319 | CISPLATIN + ETOPOSIDE |
| 240016256 | 240008484 | null | 80.9 | Neo-adjuvant (N) | 2015-07-19 | 2015-07-21 | Methotrexate High Dose (3g/m2) | N | N | 240035356 | HYDROXYCARBAMIDE |
| 240016257 | 240008498 | 1.72 | 48.5 | Palliative (P) | 2018-04-21 | 2018-12-26 | ABVD | N | N | 240035459 | CYCLOPHOSPHAMIDE |
| 240016258 | 240008499 | null | 61 | Palliative (P) | 2015-01-19 | 2015-02-15 | Carboplatin + Etoposide IV 3 day | Y | N | 240035460 | LEAM |
| 240016259 | 240008513 | 1.65 | 70 | Curative (C) | 2016-12-31 | 2017-09-29 | Chlorambucil | null | N | 240035551 | CHLORAMBUCIL |
| 240016260 | 240008521 | 1.74 | null | null | 2015-10-27 | 2015-10-27 | Methotrexate High Dose (3g/m2) | N | N | 240035582 | CARBOPLATIN + ETOPOSIDE |
| 240016261 | 240008531 | 1.88 | 65.8 | Palliative (P) | 2016-03-28 | 2016-04-03 | LEAM | 02 | N | 240000290 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 240016262 | 240008539 | 1.73 | 63.5 | Palliative (P) | 2018-09-15 | 2019-05-27 | Methotrexate High Dose (3g/m2) | N | N | 240000791 | LENALIDOMIDE |
| 240016263 | 240012572 | 1.67 | null | Disease modification (D) | 2017-06-08 | 2017-10-16 | CARBOPLATIN + ETOPOSIDE | N | N | 240001549 | DA |
| 240016264 | 240012581 | null | 65 | Curative (C) | 2017-04-03 | 2017-05-31 | Cytarabine low (10to20mg/m2) IV/SC | 02 | N | 240002486 | IBRUTINIB |
| 240016265 | 240012587 | 1.63 | null | Palliative (P) | 2017-06-15 | 2017-06-15 | R IVAC | N | N | 240003250 | ABVD |
| 240016266 | 240008682 | 1.71 | 100 | Disease modification (D) | 2017-05-26 | 2017-05-27 | Cytarabine HD + Methotrexate HD | 02 | N | 240009661 | CYTARABINE HIGH DOSE |
| 240016267 | 240008713 | null | 73.5 | Palliative (P) | null | 2019-01-14 | DTPACE | N | N | 240011523 | TRIPLE INTRATHECAL |
| 240016268 | 240015437 | 1.75 | 73.4 | Palliative (P) | 2016-05-24 | 2016-05-24 | Pemetrexed | 2 | N | 240012317 | OFATUMUMAB |
| 240016269 | 240008743 | 1.6 | 122 | Curative (C) | null | 2017-06-29 | VINORELBINE | N | N | 240012938 | CARBOPLATIN + RT |
| 240016270 | 240014527 | 1.57 | null | Curative (C) | 2018-10-17 | 2018-11-04 | RUXOLITINIB | N | null | 240016111 | BEVACIZUMAB + CARBO + GEMCITABINE |
| 240016271 | 240008792 | 1.66 | null | Palliative (P) | 2018-12-19 | 2018-12-19 | IGEV R | N | N | 240017201 | ESHAP R |
| 240016272 | 240008806 | 1.81 | 83.4 | Palliative (P) | 2016-09-27 | 2017-01-10 | PMitCEBO-R | N | Y | 240018081 | DOCETAXEL + NINTEDANIB |
| 240016273 | 240016338 | 1.67 | 75.3 | Curative (C) | 2018-09-20 | 2018-09-24 | Cytarabine High Dose | 2 | N | 240019353 | BEACOPP |
| 240016274 | 240008835 | 1.75 | 62 | Curative (C) | 2018-11-11 | 2018-11-26 | CYCLOPHOSPHAMIDE + VINBLASTINE | N | N | 240020386 | CVP |
| 240016275 | 240012722 | 0 | 59.9 | Palliative (P) | 2020-05-28 | 2020-05-31 | PIXANTRONE | N | N | 240020689 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE |
| 240016276 | 240008850 | 1.74 | 91.4 | Disease modification (D) | 2016-04-03 | 2016-04-15 | FLAG | N | N | 240020856 | UKALL2014 |
| 240016277 | 240008871 | 1.65 | 59.05 | Palliative (P) | 2017-12-27 | 2018-01-09 | BEVACIZUMAB + CARBO | N | N | 240021767 | FBC |
| 240016278 | 240008914 | 1.82 | 57 | Palliative (P) | null | 2018-07-22 | Cladribine (subcut) 5 days | N | N | 240023687 | AML17 TRIAL |
| 240016279 | 240014565 | 1.6 | 82.8 | Curative (C) | 2018-09-10 | 2018-09-13 | Triple Intrathecal | N | N | 240023735 | DHAP - R |
| 240016280 | 240008924 | 0 | 61 | Palliative (P) | 2016-12-12 | 2016-12-18 | Vinblastine | N | N | 240023933 | ICE-R |
| 240016281 | 240009008 | null | 79.8 | Curative (C) | 2018-10-21 | 2018-10-21 | AML 19 TRIAL | 02 | N | 240007272 | TOPOTECAN |
| 240016282 | 240012827 | null | 40.2 | Palliative (P) | 2018-01-17 | 2018-02-14 | Cytarabine High Dose | 02 | N | 240015030 | CARBOPLATIN + TOPOTECAN |
| 240016283 | 240005570 | 1.62 | 55.9 | null | 2019-07-14 | 2019-07-26 | Rituximab | N | N | 240000683 | RITUXIMAB |
| 240016284 | 240005775 | 1.7 | 79.4 | Disease modification (D) | null | 2019-03-28 | Rituximab | N | N | 240004078 | RITUXIMAB |
| 240016285 | 240005976 | 1.8 | 80.4 | Palliative (P) | 2014-08-29 | 2014-09-05 | Rituximab | 02 | N | 240006843 | RITUXIMAB |
| 240016286 | 240006210 | 1.55 | 67.5 | Curative (C) | 2020-12-15 | 2020-12-16 | Rituximab | 02 | N | 240009601 | RITUXIMAB |
| 240016287 | 240011414 | 1.62 | 100 | Curative (C) | 2018-02-24 | 2018-08-15 | Rituximab | 02 | N | 240010325 | RITUXIMAB |
| 240016288 | 240006357 | 1.5 | null | Curative (C) | 2016-06-05 | 2016-06-05 | Rituximab (SUBCUTANEOUS Maintenance) | 02 | N | 240010555 | RITUXIMAB |
| 240016289 | 240006389 | 1.58 | 70.2 | Curative (C) | 2015-11-27 | 2016-04-29 | Rituximab (SUBCUTANEOUS Maintenance) | 02 | N | 240010759 | RITUXIMAB |
| 240016290 | 240015735 | 1.58 | 70.4 | Disease modification (D) | 2018-07-15 | 2018-07-20 | Rituximab | 02 | N | 240011479 | RITUXIMAB |
| 240016291 | 240006593 | 1.73 | 90 | Curative (C) | 2014-12-09 | 2014-12-10 | Rituximab | 2 | N | 240011964 | RITUXIMAB |
| 240016292 | 240006727 | 1.8 | 115 | Palliative (P) | 2015-09-20 | 2016-02-21 | Rituximab (Maintenance) | N | N | 240023901 | RITUXIMAB |
| 240016293 | 240006789 | 1.72 | 60.5 | null | 2018-09-17 | 2018-09-18 | Rituximab (SUBCUTANEOUS Maintenance) | null | Y | 240024259 | RITUXIMAB |
| 240016294 | 240006822 | null | 57 | Curative (C) | 2018-03-07 | 2018-03-14 | Rituximab (Maintenance) | 02 | Y | 240024459 | RITUXIMAB |